| Followers | 902 |
| Posts | 38372 |
| Boards Moderated | 13 |
| Alias Born | 03/22/2016 |
Wednesday, January 08, 2025 4:35:37 AM
Recent DRTS News
- Alpha Tau Announces Presentation of Two Alpha DaRT Pancreatic Cancer Abstracts at Upcoming 2026 ASCO GI Symposium • GlobeNewswire Inc. • 12/04/2025 02:00:00 PM
- Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Locally Recurrent Prostate Cancer • GlobeNewswire Inc. • 12/02/2025 02:00:00 PM
- Alpha Tau to Participate in December Investor Conferences • GlobeNewswire Inc. • 12/01/2025 02:00:00 PM
- Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/20/2025 09:05:00 PM
- Alpha Tau to Participate at Jefferies Global Healthcare Conference in London • GlobeNewswire Inc. • 11/11/2025 01:30:00 PM
- Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness • GlobeNewswire Inc. • 10/21/2025 12:30:00 PM
- Alpha Tau Successfully Treats First Patient in its U.S. Multi-Center Pancreatic Cancer Clinical Trial • GlobeNewswire Inc. • 09/02/2025 12:30:00 PM
- Alpha Tau to Participate in Five September Investor Conferences • GlobeNewswire Inc. • 08/27/2025 12:30:00 PM
- Alpha Tau Announces Second Quarter 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/11/2025 08:02:00 PM
- Alpha Tau to Present at Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/28/2025 12:30:00 PM
- Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/19/2025 08:01:00 PM
- Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors • GlobeNewswire Inc. • 05/12/2025 08:01:00 PM
- Alpha Tau to Participate in May Investor Conferences • GlobeNewswire Inc. • 05/06/2025 12:30:00 PM
- Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical • PR Newswire (US) • 04/28/2025 01:00:00 PM
- Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals • GlobeNewswire Inc. • 04/28/2025 01:00:00 PM
- Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma • GlobeNewswire Inc. • 04/02/2025 12:30:00 PM
- Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/12/2025 08:02:00 PM
- Alpha Tau to Participate in March Investor Conferences • GlobeNewswire Inc. • 02/27/2025 02:00:00 PM
- Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification • GlobeNewswire Inc. • 02/24/2025 01:30:00 PM
- Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease • GlobeNewswire Inc. • 02/03/2025 01:30:00 PM
- Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day • GlobeNewswire Inc. • 01/27/2025 02:00:00 PM
- Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day • GlobeNewswire Inc. • 12/18/2024 01:30:00 PM
- Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor • GlobeNewswire Inc. • 12/17/2024 02:00:00 PM
- Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/11/2024 01:30:00 PM
Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations • SNGX • Dec 4, 2025 10:18 AM
I-ON Digital Corp. Deploys $200 Million in Assets Under Management (AUM), Backed By In Situ Gold Reserves, As I-ON's Treasury Solidifies Diversified Yield Strategies From Digital Asset Deployment • IONI • Dec 4, 2025 8:30 AM
Metavesco Fast-Tracks OTC Prediction Market Platform • MVCO • Dec 3, 2025 9:12 AM
Scientists Pointing to Hidden Power Source That Could Reshape Future of AI • MAXXF • Dec 3, 2025 9:00 AM
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now • PFE • Dec 2, 2025 9:00 AM
Cannabix Technologies Strengthens Presence in Maritime Market with Repeat BreathLogix Alcohol Screening Device Order • BLO • Dec 2, 2025 8:50 AM
